Genmab Reports Positive Results From Three Phase 3 Trials
Genmab reported positive results from three Phase 3 trials. The headline says the trials support potential launches in 2027.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Genmab reported positive results from three Phase 3 trials. The headline says the trials support potential launches in 2027.
Genmab reported positive results from three Phase 3 studies of cancer drugs.